Congratulations to the Cruinn Diagnostics team on reaching this milestone. We are delighted to be joining forces and look forward to building on their success as they continue shaping the future of healthcare diagnostics. See the full press release here: https://lnkd.in/dHgS9Be6 #PrivateEquity #Healthcare #Diagnostics #Innovation #Growth
A New Chapter for Cruinn Diagnostics We are delighted to announce that Waterland Private Equity and MML Capital Partners Ireland have agreed terms on the acquisition of Cruinn Diagnostics. Since our founding in 1998, Cruinn has grown into a leading provider of laboratory diagnostic equipment, reagents, consumables, and calibration services across Ireland. Today, with a team of over 90 colleagues nationwide and revenues of €45m in 2024, we are proud to serve hospitals, independent testing laboratories, universities, research institutions, and the life sciences sector. This major investment marks an exciting milestone in our journey. Partnering with Waterland will accelerate our growth plans and enable us to launch next-generation healthcare diagnostics, helping deliver better patient outcomes across the country. We would like to sincerely thank MML Ireland for their partnership since 2021. Their guidance and support were instrumental in scaling our business, adding new supplier relationships, and strengthening our leadership position in the Irish diagnostics market. As we look ahead, we are excited to continue innovating, growing, and working closely with our customers and partners to deliver the highest quality diagnostics solutions. Please read the full press release here: https://lnkd.in/eEh-cJVU #Healthcare #Diagnostics #Innovation #Growth #LifeSciences